1. Home
  2. PRTA vs HLLY Comparison

PRTA vs HLLY Comparison

Compare PRTA & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • HLLY
  • Stock Information
  • Founded
  • PRTA 2012
  • HLLY 1903
  • Country
  • PRTA Ireland
  • HLLY United States
  • Employees
  • PRTA N/A
  • HLLY N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • HLLY Auto Parts:O.E.M.
  • Sector
  • PRTA Health Care
  • HLLY Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • HLLY Nasdaq
  • Market Cap
  • PRTA 346.4M
  • HLLY 353.7M
  • IPO Year
  • PRTA N/A
  • HLLY N/A
  • Fundamental
  • Price
  • PRTA $6.41
  • HLLY $2.14
  • Analyst Decision
  • PRTA Buy
  • HLLY Strong Buy
  • Analyst Count
  • PRTA 9
  • HLLY 6
  • Target Price
  • PRTA $27.67
  • HLLY $5.21
  • AVG Volume (30 Days)
  • PRTA 1.7M
  • HLLY 535.3K
  • Earning Date
  • PRTA 08-07-2025
  • HLLY 08-06-2025
  • Dividend Yield
  • PRTA N/A
  • HLLY N/A
  • EPS Growth
  • PRTA N/A
  • HLLY N/A
  • EPS
  • PRTA N/A
  • HLLY N/A
  • Revenue
  • PRTA $137,935,000.00
  • HLLY $596,632,000.00
  • Revenue This Year
  • PRTA N/A
  • HLLY $0.08
  • Revenue Next Year
  • PRTA $122.02
  • HLLY $4.60
  • P/E Ratio
  • PRTA N/A
  • HLLY N/A
  • Revenue Growth
  • PRTA 54.55
  • HLLY N/A
  • 52 Week Low
  • PRTA $4.32
  • HLLY $1.60
  • 52 Week High
  • PRTA $25.42
  • HLLY $4.08
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 57.61
  • HLLY 50.82
  • Support Level
  • PRTA $5.96
  • HLLY $2.16
  • Resistance Level
  • PRTA $6.77
  • HLLY $2.32
  • Average True Range (ATR)
  • PRTA 0.36
  • HLLY 0.09
  • MACD
  • PRTA 0.14
  • HLLY 0.02
  • Stochastic Oscillator
  • PRTA 75.80
  • HLLY 55.00

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

Share on Social Networks: